Trials / Completed
CompletedNCT00868712
Warfarin and Coronary Calcification Project
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Walter Reed Army Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess whether the use of warfarin, a commonly used anticoagulation drug, is associated with increased amounts of coronary artery calcification. Studies in animals and preliminary but small retrospective studies in humans have suggested a possible link to increased tissue calcification with use of this drug. The researchers will investigate this by assessing the amount of calcification seen in the coronary arteries using a specialized computed tomography (CT) scan (electron-beam CT) and assessing to see if the amount is influenced by the amount of time a patient has been taking warfarin. The researchers will exclude patients with known coronary artery disease, chronic kidney disease or hyperparathyroidism.
Conditions
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-03-25
- Last updated
- 2012-08-24
- Results posted
- 2012-08-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00868712. Inclusion in this directory is not an endorsement.